UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The microbial basis of inflammatory bowel diseases

The Journal of clinical investigation, 2014-10, Vol.124 (10), p.4190-4196

2014

Volltextzugriff (PDF)

The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer

PloS one, 2011-01, Vol.6 (1), p.e16221

2011

Volltextzugriff (PDF)

S3848 Treatment of Refractory CVID Enteropathy With Ustekinumab

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S2516-S2516

2024

Volltextzugriff (PDF)

The Role of the Microbiome in the Etiology of Inflammatory Bowel Diseases

Clinics in colon and rectal surgery, 2023-03, Vol.36 (2), p.120-126

2023

Volltextzugriff (PDF)

Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease

Clinical gastroenterology and hepatology, 2021-01, Vol.19 (1), p.104-110

2021

Volltextzugriff (PDF)

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (7), p.1913-1923.e2

2023

Volltextzugriff (PDF)

S1141 Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S873-S874

2023

Volltextzugriff (PDF)

S1190 Colonic Tissue Expression of MAdCAM-1 Is Associated With Response to Vedolizumab in Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2024-10, Vol.119 (10S), p.S846-S846

2024

Volltextzugriff (PDF)

Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis

Inflammatory bowel diseases, 2015-07, Vol.21 (7), p.1719-1736

2015

Volltextzugriff (PDF)

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

Digestive diseases and sciences, 2019-12, Vol.64 (12), p.3596-3601

2019

Volltextzugriff (PDF)

Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.293-302.e9

2022

Volltextzugriff (PDF)

S1094 Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S834-S834

2023

Volltextzugriff (PDF)

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis

Alimentary pharmacology & therapeutics, 2020-03, Vol.51 (6), p.637-643

2020

Volltextzugriff (PDF)

Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease

Gastrointestinal endoscopy, 2019-08, Vol.90 (2), p.269-275

2019

Volltextzugriff (PDF)

Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes

Clinical gastroenterology and hepatology, 2021-11, Vol.19 (11), p.2444-2446.e2

2021

Volltextzugriff (PDF)

Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch–Anal Anastomosis in Pediatric Ulcerative Colitis

Inflammatory bowel diseases, 2022-09, Vol.28 (9), p.1386-1394

2022

Volltextzugriff (PDF)

Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center

Digestive diseases and sciences, 2024-02, Vol.69 (2), p.579-587

2024

Volltextzugriff (PDF)

Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes

Digestive diseases and sciences, 2023-04, Vol.68 (4), p.1464-1472

2023

Volltextzugriff (PDF)

S2442 Successive Use of Infliximab and Cyclosporine as Salvage Therapy in Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1033-S1033

2021

Volltextzugriff (PDF)

Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2785-2793

2021

Volltextzugriff (PDF)

Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease

Inflammatory bowel diseases, 2024-06

2024

Volltextzugriff (PDF)

Follow-Up of Patients With Ulcerative Colitis and Histological Normalization

Clinical gastroenterology and hepatology, 2020-04, Vol.18 (4), p.987-988.e1

2020

Volltextzugriff (PDF)

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Intestinal research, 2022, 20(2), , pp.240-250

2022

Volltextzugriff (PDF)

S725 Utility of Serum Cytomegalovirus Polymerase Chain Reaction Test in the Setting of Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S331-S332

2021

Volltextzugriff (PDF)

S871 Patients Hospitalized With Acute Severe Ulcerative Colitis Undergoing Colectomy Within Three Months Have Lower Oral Cyclosporine Levels

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S407-S408

2021

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(162)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The microbial basis of inflammatory bowel diseases

The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer

S3848 Treatment of Refractory CVID Enteropathy With Ustekinumab

The Role of the Microbiome in the Etiology of Inflammatory Bowel Diseases

Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease

Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn’s Disease: Prospective Real-World Experience

S1141 Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience

S1190 Colonic Tissue Expression of MAdCAM-1 Is Associated With Response to Vedolizumab in Patients With Inflammatory Bowel Disease

Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes

S1094 Effectiveness and Safety of Risankizumab Induction Therapy in Crohn’s Disease: Prospective Real-World Experience in a Large Tertiary Center

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis

Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn’s disease

Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes

Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch–Anal Anastomosis in Pediatric Ulcerative Colitis

Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center

Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes

S2442 Successive Use of Infliximab and Cyclosporine as Salvage Therapy in Acute Severe Ulcerative Colitis

Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's disease

Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease

Follow-Up of Patients With Ulcerative Colitis and Histological Normalization

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

S725 Utility of Serum Cytomegalovirus Polymerase Chain Reaction Test in the Setting of Acute Severe Ulcerative Colitis

S871 Patients Hospitalized With Acute Severe Ulcerative Colitis Undergoing Colectomy Within Three Months Have Lower Oral Cyclosporine Levels

Suchergebnisse filtern